CGTX
Price
$0.37
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
23.08M
18 days until earnings call
SNDX
Price
$11.54
Change
+$0.49 (+4.43%)
Updated
Apr 17 closing price
Capitalization
992.95M
23 days until earnings call
Ad is loading...

CGTX vs SNDX

Header iconCGTX vs SNDX Comparison
Open Charts CGTX vs SNDXBanner chart's image
Cognition Therapeutics
Price$0.37
Change-$0.00 (-0.00%)
Volume$276.82K
Capitalization23.08M
Syndax Pharmaceuticals
Price$11.54
Change+$0.49 (+4.43%)
Volume$1.95M
Capitalization992.95M
CGTX vs SNDX Comparison Chart
Loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGTX vs. SNDX commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a Hold and SNDX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (CGTX: $0.37 vs. SNDX: $11.54)
Brand notoriety: CGTX and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 18% vs. SNDX: 96%
Market capitalization -- CGTX: $23.08M vs. SNDX: $992.95M
CGTX [@Biotechnology] is valued at $23.08M. SNDX’s [@Biotechnology] market capitalization is $992.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 1 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • CGTX’s FA Score: 1 green, 4 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CGTX and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • CGTX’s TA Score: 5 bullish, 3 bearish.
  • SNDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGTX is a better buy in the short-term than SNDX.

Price Growth

CGTX (@Biotechnology) experienced а +16.59% price change this week, while SNDX (@Biotechnology) price change was +9.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

CGTX is expected to report earnings on Aug 12, 2025.

SNDX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($993M) has a higher market cap than CGTX($23.1M). SNDX YTD gains are higher at: -12.708 vs. CGTX (-46.899). CGTX has higher annual earnings (EBITDA): -33.68M vs. SNDX (-313.82M). SNDX has more cash in the bank: 583M vs. CGTX (25M). CGTX has less debt than SNDX: CGTX (814K) vs SNDX (346M). SNDX has higher revenues than CGTX: SNDX (23.7M) vs CGTX (0).
CGTXSNDXCGTX / SNDX
Capitalization23.1M993M2%
EBITDA-33.68M-313.82M11%
Gain YTD-46.899-12.708369%
P/E RatioN/AN/A-
Revenue023.7M-
Total Cash25M583M4%
Total Debt814K346M0%
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
83
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXSNDX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 12 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 4 days ago
74%
View a ticker or compare two or three
Ad is loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

CGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGTX has been loosely correlated with CLDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CGTX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
-0.21%
CLDX - CGTX
34%
Loosely correlated
+2.81%
SNDX - CGTX
32%
Poorly correlated
+4.43%
RLAY - CGTX
30%
Poorly correlated
+3.07%
MRNA - CGTX
30%
Poorly correlated
-1.89%
BRCTF - CGTX
30%
Poorly correlated
N/A
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with ETNB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+4.43%
ETNB - SNDX
48%
Loosely correlated
+2.89%
NGNE - SNDX
47%
Loosely correlated
+6.69%
KYMR - SNDX
44%
Loosely correlated
+3.80%
IDYA - SNDX
44%
Loosely correlated
+5.56%
KRYS - SNDX
43%
Loosely correlated
+2.35%
More